An antibody in single-chain fragment variable (scFv) format that binds to the powerful opioid carfentanil was shown to reverse signs of carfentanil overdose in preclinical tests conducted by scientists at Scripps Research.
Aug 7, 2023
0
40
Vanderbilt University Medical Center and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
Aug 7, 2023
0
47
Exceptionally potent antibodies that can neutralize virtually all known variants of the COVID-19 virus—including omicron, as well as other dangerous animal coronaviruses that could potentially cause future outbreaks—have ...
Jul 28, 2023
0
338
A new technology developed at Caltech is designed to make more potent vaccines, beginning with SARS-CoV-2 (the virus that causes COVID-19). In mouse studies, the prototype vaccine elicited five times more antibodies than ...
Jul 25, 2023
0
42
The first ever clinical trial of a new class of immunotherapy for cancer has shown promising results that could benefit patients who do not respond to existing cancer treatments.
Jul 25, 2023
0
43
An anonymous San Diego resident has become a fascinating example of how the human immune system fights SARS-CoV-2. In a new investigation, scientists from La Jolla Institute for Immunology (LJI) have shown how antibodies, ...
Apr 25, 2023
0
73
Is it possible to improve the antibodies that the body produces to fight SARS-CoV2? In a study led by researchers from Lund University in Sweden, this was investigated by redesigning antibodies and combining them against ...
Apr 18, 2023
0
108
A new nuclear medicine therapy can cure human non-Hodgkin's lymphoma in an animal model, according to research published in the April issue of the Journal of Nuclear Medicine. A single dose of the radioimmunotherapy, [177Lu]Lu-ofatumumab, ...
Apr 11, 2023
0
356
The human body is capable of creating a vast, diverse repertoire of antibodies—the Y-shaped sniffer dogs of the immune system that can find and flag foreign invaders. Despite our ability to create a range of antibodies ...
Apr 6, 2023
0
130
The rapid evolution and emergence of new SARS-CoV-2 variants, such as the omicron variant, renders it highly capable of evading the host immunity.
Mar 22, 2023
0
27
